research Adverse effects of baricitinib in comparison to methotrexate in the treatment of severe alopecia areata
This study compared the adverse effects of baricitinib and methotrexate in treating severe alopecia areata and found baricitinib to have a better safety profile, though it was associated with increased cholesterol, triglyceride, and LDL levels.
